Literature DB >> 655230

Patient tolerance to carbonic anhydrase inhibitors.

P R Lichter, L P Newman, N C Wheeler, O V Beall.   

Abstract

We evaluated carbonic anhydrase inhibitors in a crossover study with a placebo and random allocation of treatment administration. Drugs evaluated included acetazolamide tablets and Sequels, dichlorphenamide, ethoxzolamide, methazolamide, and an ascorbic acid placebo. The best tolerated drug was acetazolamide Sequels. Methazolamide was next. The least tolerated drugs were ethoxzolamide, acetazolamide tablets, and dichlorphenamide.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 655230     DOI： 10.1016/s0002-9394(14)75247-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


  11 in total

Review 1.  The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.

Authors:  A J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Comparison of the effect of acetazolamide tablets and sustets on diurnal intraocular pressure in patients with chronic simple glaucoma.

Authors:  P W Joyce; K B Mills
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

3.  L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.

Authors:  M F Sugrue; P Gautheron; P Mallorga; T E Nolan; S L Graham; H Schwam; K L Shepard; R L Smith
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

Review 4.  Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension.

Authors:  J A Balfour; M I Wilde
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

Review 5.  A risk-benefit assessment of drugs used in the management of glaucoma.

Authors:  T Taniguchi; Y Kitazawa
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

Review 6.  New developments in the drug treatment of glaucoma.

Authors:  L M Hurvitz; P L Kaufman; A L Robin; R N Weinreb; K Crawford; B Shaw
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

Review 7.  Skeletal Muscle Channelopathies.

Authors:  Lauren Phillips; Jaya R Trivedi
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

8.  Present and New Treatment Strategies in the Management of Glaucoma.

Authors:  Kolko M
Journal:  Open Ophthalmol J       Date:  2015-05-15

Review 9.  Review of the Diagnosis and Treatment of Periodic Paralysis.

Authors:  Jeffrey M Statland; Bertrand Fontaine; Michael G Hanna; Nicholas E Johnson; John T Kissel; Valeria A Sansone; Perry B Shieh; Rabi N Tawil; Jaya Trivedi; Stephen C Cannon; Robert C Griggs
Journal:  Muscle Nerve       Date:  2017-11-29       Impact factor: 3.217

Review 10.  Managing adverse effects of glaucoma medications.

Authors:  Kenji Inoue
Journal:  Clin Ophthalmol       Date:  2014-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.